Assignee
SHANGHAI APEIRON THERAPEUTICS COMPANY LTD
CN·1 granted patent·5 pending applications·0 citations·filing 2022–2024
Top patents by PatentIndex Score
6 records- 0167US12173002B2PRMT5 inhibitors and methods of useSHANGHAI APEIRON THERAPEUTICS COMPANY LTD·Filed 2024·Granted Dec 24, 2024·0 cites·16 claims
- 0266US2025051331A1Prmt5 inhibitors and methods of useSHANGHAI APEIRON THERAPEUTICS COMPANY LTD·Filed 2024·Application pending·0 cites
- 0356US2025066368A1Dna polymerase theta inhibitor and use thereofSHANGHAI APEIRON THERAPEUTICS COMPANY LTD·Filed 2022·Application pending·0 cites
- 0453US2026049089A1Kras inhibitor compoundSHANGHAI APEIRON THERAPEUTICS COMPANY LTD·Filed 2023·Application pending·0 cites
- 0552US2025304551A1Kinesin kif18a inhibitor and use thereofSHANGHAI APEIRON THERAPEUTICS COMPANY LTD·Filed 2023·Application pending·0 cites
- 0647US2024166664A1Triheterocyclic compound, preparation method therefor, and application thereofSHANGHAI APEIRON THERAPEUTICS COMPANY LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI APEIRON THERAPEUTICS COMPANY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →